AppLovin: UBS Raises Price Target to $810
UBS hiked AppLovin's stock target to $810, calling it a "top pick". They expect better Axon 2.0 tech and solid advertiser demand.
Already have an account? Sign in.
UBS hiked AppLovin's stock target to $810, calling it a "top pick". They expect better Axon 2.0 tech and solid advertiser demand.
The Florida-based surgical device maker faces margin pressures but sees strong interest from acquirers.
Concerns grow over the platform’s independence as it hits 30 million users.
Bank of America calls Meta’s custom AI chip progress and faster, cheaper 14GW infrastructure buildout a “big positive.” Iris production starts September 2026.